| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $344.0M | — | +67.2% |
| SG&A Expense | $101.3M | — | +189.2% |
| Operating Income | -$445.2M | — | -84.9% |
| Pre-tax Income | -$453.8M | — | -112.6% |
| Net Income | -$453.8M | — | -112.6% |
| EPS (Basic) | -$2.29 | — | -102.7% |
| EPS (Diluted) | -$2.29 | — | -102.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $440.9M | +14.9% | +32.2% |
| Short-term Investments | $1.47B | -10.6% | -17.1% |
| Current Assets | $1.97B | -5.2% | -7.8% |
| Total Assets | $2.25B | -4.3% | -4.7% |
| Current Liabilities | $289.6M | -0.3% | +82.6% |
| Total Liabilities | $753.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$354.2M | — | -82.2% |
| Capital Expenditures | $1.5M | — | -52.9% |
| Investing Cash Flow | $172.6M | — | +1182.3% |
| Financing Cash Flow | $238.7M | — | — |
| Free Cash Flow | -$355.7M | — | -79.9% |
| +162.5% |
| Stockholders' Equity | $1.50B | -8.1% | -27.8% |